ABOUT US

Management Team

Jonathan Fiteni – Director, CEO

Jonathan Fiteni is a cannabis pioneer who has worked over 15 years to actively bridge the divide between global investment capital and legal growers, suppliers, researchers, and medical professionals who have dedicated their lives to transforming the cannabis industry. Mr. Fiteni has guided several industry startups, raised millions in capital for both private and public companies and developed more than 40 patent pending cannabis formulations. Most recently Mr. Fiteni was the CEO and Director of Operations for MYM Nutraceuticals, Inc. a publicly listed (CSE) company focused on building large, licensed production facilities to serve the pharmaceutical-grade and recreational cannabis markets. Mr. Fiteni graduated from the British Columbia Institute of Technology with a Business Administration and Management degree.


Robin Linden – Director

Robin Linden contributes over 20 years of leadership and management experience, including roles at the University of Manitoba, Molson Breweries Canada, Canadian luxury retailer – Holt Renfrew, and Fairmont Hotels and Resorts. Mr. Linden currently sits on the board of directors for MYM Nutraceuticals, a publicly traded Canadian medical cannabis company. He has been instrumental in initiating various projects, including the current construction of over 2.7 million square feet of cannabis production space in Canada and Australia. Mr. Linden brings with him experience in the branding and sales of a variety of cannabis-based products. Mr. Linden holds a Bachelor of Arts degree (with honours) from the University of Manitoba and obtained post graduate diplomas from both Simon Fraser University (Vancouver) and the University of St. Andrews (Scotland).


Chris Cherry – Director, CFO

Christopher Cherry has over 15 years of corporate accounting and audit experience, having been a Chartered Accountant (CA) since February 2009 and a Certified General Accountant (CGA) since 2004. Mr. Cherry has held a number of senior level positions, including as a Senior Accountant at KPMG and as an Auditor at Davidson and Co. LLP in Vancouver. Mr. Cherry has also served at the director and officer levels for a number of public mining companies. Mr. Cherry is the founder of Cherry Consulting, Ltd. Mr. Cherry earned a Bachelors of Technology in Accounting from the British Columbia Institute of Technology.

Management Team

Jonathan Fiteni – CEO, Director

Jonathan Fiteni is a cannabis pioneer who has worked over 15 years to actively bridge the divide between global investment capital and legal growers, suppliers, researchers, and medical professionals who have dedicated their lives to transforming the cannabis industry. Mr. Fiteni has guided several industry startups, raised millions in capital for both private and public companies and developed more than 40 patent pending cannabis formulations. Most recently Mr. Fiteni was the CEO and Director of Operations for MYM Nutraceuticals, Inc. a publicly listed (CSE) company focused on building large, licensed production facilities to serve the pharmaceutical-grade and recreational cannabis markets. Mr. Fiteni graduated from the British Columbia Institute of Technology with a Business Administration and Management degree.


Chris Cherry – Director, CFO

Christopher Cherry has over 15 years of corporate accounting and audit experience, having been a Chartered Accountant (CA) since February 2009 and a Certified General Accountant (CGA) since 2004. Mr. Cherry has held a number of senior level positions, including as a Senior Accountant at KPMG and as an Auditor at Davidson and Co. LLP in Vancouver. Mr. Cherry has also served at the director and officer levels for a number of public mining companies. Mr. Cherry is the founder of Cherry Consulting, Ltd. Mr. Cherry earned a Bachelors of Technology in Accounting from the British Columbia Institute of Technology.


Robin Linden – Director

Robin Linden contributes over 20 years of leadership and management experience, including roles at the University of Manitoba, Molson Breweries Canada, Canadian luxury retailer – Holt Renfrew, and Fairmont Hotels and Resorts. Mr. Linden currently sits on the board of directors for MYM Nutraceuticals, a publicly traded Canadian medical cannabis company. He has been instrumental in initiating various projects, including the current construction of over 2.7 million square feet of cannabis production space in Canada and Australia. Mr. Linden brings with him experience in the branding and sales of a variety of cannabis-based products. Mr. Linden holds a Bachelor of Arts degree (with honours) from the University of Manitoba and obtained post graduate diplomas from both Simon Fraser University (Vancouver) and the University of St. Andrews (Scotland).